據(jù)歐盟食品安全局消息，7月28日歐盟食品安全局發(fā)布了發(fā)酵大豆提取物NSK-SDportant; font: 14px/19px Verdana, Helvetica, Arial, sans-serif; white-space: normal; float: none; letter-spacing: normal; color: rgb(103,103,103); word-spacing: 0px; -webkit-text-stroke-width: 0px">® 作為新資源食品的安全性。
發(fā)酵大豆提取物NSK-SD?經(jīng)過標準處理后納豆激酶酶活性為20,000-28,000纖維蛋白降解單位/克。歐盟評估小組認為發(fā)酵大豆提取物NSK-SDportant; font: 14px/19px Verdana, Helvetica, Arial, sans-serif; white-space: normal; float: none; letter-spacing: normal; color: rgb(103,103,103); word-spacing: 0px; -webkit-text-stroke-width: 0px">® 的產(chǎn)品說明、批次差異性以及穩(wěn)定性較好不存在安全隱患。作為膳食補充劑每天的限量為100mgNSK-SDportant; font: 14px/19px Verdana, Helvetica, Arial, sans-serif; white-space: normal; float: none; letter-spacing: normal; color: rgb(103,103,103); word-spacing: 0px; -webkit-text-stroke-width: 0px">® ，適宜人群為35歲以上健康人群，孕婦和哺乳期婦女除外。
部分原文報道如下：
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies （NDA） was asked to deliver an opinion on the fermented soybean extract NSK-SD? as a novel food （NF） submitted pursuant to Regulation （EC） No 258/97 of the European Parliament and of the Council, taking into account the comments and objections of a scientific nature raised by Member States. The NF is the fermented soybean extract NSK-SD?, which is standardised to a nattokinase enzyme activity of 20,000-28,000 fibrin degradation units/g.
原文鏈接：<http://www.efsa.europa.eu/en/efsajournal/pub/4541>
日期：2016-08-01
